Chitosan-based systems for intranasal immunization against foot-and-mouth disease

References

• Tsuda T, Namba K, Yamasaki Y, et al. Quantitative single radial immunodiffusion of foot-and-mouth disease viral antigens using convalescent cattle sera. Nippon Juigaku Zasshi 1987;49:461–8
   PubMedGoogle Scholar
• Radostits OM, Blood DC, Gay CC. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats and horses. London: Bailliere Tindall; 1994
   Google Scholar
• Alexandersen S, Zhang Z, Donaldson AI. Aspects of the persistence of foot-and-mouth disease virus in animals: the carrier problem. Microbes Infect 2002;4:1099–110
   PubMed Web of Science ®Google Scholar
• Hedger RS, Condy JB. Transmission of foot-and-mouth disease from African buffalo virus carriers to bovines. Vet Rec 1985;117:205
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Moraes MP, Koster M, Grubman MJ. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol 2003;77:1621–5
   PubMed Web of Science ®Google Scholar
• Fischer D, Rood D, Barrette RW, et al. Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge. J Virol 2003;77:7486–91
   PubMed Web of Science ®Google Scholar
• van Ginkel FW, Nguyen HH, McGhee JR. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infect Dis 2000;6:123–32
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Verhoef JC, et al. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Vaccine 2007;25:144–53
   PubMed Web of Science ®Google Scholar
• Illum L, Jabbal-Gill I, Hinchcliffe M, et al. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 2001;51:81–96
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci 2000;89:850–66
   PubMed Web of Science ®Google Scholar
• Arca HC, Gunbeyaz M, Şenel S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 2009;8:937–53
   PubMed Web of Science ®Google Scholar
• Şenel S. Chitosan based particulate systems for non-invasive vaccine delivery advances in polymer science. Vol. 239. Berlin: Springer; 2011:1–28
   Google Scholar
• Şenel S, McClure SJ. Potential applications of chitosan in veterinary medicine. Adv Drug Deliv Rev 2004;56:1467–80
   PubMed Web of Science ®Google Scholar
• Sutmoller P, Barteling SS, Olascoaga RC, Sumption KJ. Control and eradication of foot-and-mouth disease. Virus Res 2003;91:101–44
   PubMed Web of Science ®Google Scholar
• Garmise RJ, Staats HF, Hickey AJ. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS PharmSciTech 2007;8:2–10
   PubMed Web of Science ®Google Scholar
• Gordon S, Saupe A, McBurney W, et al. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. J Pharm Pharmacol 2008;60:1591–600
   PubMed Web of Science ®Google Scholar
• Maxwell S, Şenel, S, McClure S. Chitosan for delivery of mucosal vaccines in ruminants. 33rd Annual Meeting and Exposition of the Controlled Release Society; 2006 Jul 22–29, Vienna, Austria
   Google Scholar
• Maxwell S, Şenel S, McClure S. Mucosal vaccination of sheep with heliotrine antigen. 13th International Pharmaceutical Technology Symposium; 2006 Sep 10–13; Ankara, Turkey
   Google Scholar
• Sayin B, Somavarapu S, Li XW, et al. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. Eur J Pharm Sci 2009;8:362–9
   Google Scholar
• Sayin B, Somavarapu S, Li XW, et al. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int J Pharm 2008;363:139–48
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Verhoef JC, Borchard G, et al. Chitosan for mucosal vaccination. Adv Drug Deliv Rev 2001;52:139–44
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang X, Kang Y, et al. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 2008;26:5135–44
   PubMed Web of Science ®Google Scholar
• Iyer AV, Ghosh S, Singh SN, et al. Evaluation of three ‘ready to formulate’ oil adjuvants for foot-and-mouth disease vaccine production. Vaccine 2001;19:1097–105
   Google Scholar
• Barteling SJ, Meloen RH. A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV). Arch Gesamte Virusforsch 1974;45:362–4
   PubMedGoogle Scholar
• Bahnemann HG. Inactivation of viruses in serum with binary ethyleneimine. J Clin Microbiol 1976;3:209–10
   PubMedGoogle Scholar
• OIE. Manual of diagnostic tests and vaccines for terrestrial animals. In: O.I.d.E. (OIE) ed. Foot and mouth disease, Vol. section 2.1, Chapter 2.1.5. Paris: OIE; 2008
   Google Scholar
• Hamblin C, Barnett IT, Crowther JR. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods 1986;93:123–9
   PubMed Web of Science ®Google Scholar
• Ellis PR, James AD. The economics of animal health: (1) major disease control programmes. Vet Rec 1979;105:504–6
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005;11:S45–53
   PubMed Web of Science ®Google Scholar
• Baudner BC, Giuliani MM, Verhoef JC, et al. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. Vaccine 2003;21:3837–44
   PubMed Web of Science ®Google Scholar
• Gunbeyaz M, Faraji A, Ozkul A, et al. Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). Eur J Pharm Sci 2010;41:531–45
   PubMed Web of Science ®Google Scholar
• Kang ML, Kang SG, Jiang HL, et al. Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in pigs. J Microbiol Biotechnol 2008;18:1179–85
   PubMed Web of Science ®Google Scholar
• Nagamoto T, Hattori Y, Takayama K, Maitani Y. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 2004;216:71–4
   Google Scholar
• Şenel S. Chitin, chitosan, oligosaccharides and their derivatives biological activities and applications. Boca Raton (FL): Taylor & Francis; 2010
   Google Scholar
• Vila A, Sanchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 2004;57:123–31
   PubMed Web of Science ®Google Scholar
• Kang ML, Jiang HL, Kang SG, et al. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin. Vaccine 2007;25:4602–10
   PubMed Web of Science ®Google Scholar
• Hagenaars N, Mastrobattista E, Verheul RJ, et al. Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration. Pharm Res 2009;26:1353–64
   Web of Science ®Google Scholar
• Song H, Wang Z, Zheng D, et al. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine. Biotechnol Lett 2005;27:1669–74
   PubMed Web of Science ®Google Scholar
• Challa S, Barrette R, Rood D, et al. Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus. Vaccine 2007;25:3328–37
   PubMedGoogle Scholar
• van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol 1995;69:4511–14
   PubMedGoogle Scholar
• Bakke H, Setek TN, Huynh PN, et al. Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory. Vaccine 2004;22:2278–84
   PubMed Web of Science ®Google Scholar
• McNeela EA, Jabbal-Gill I, Illum L, et al. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine 2004;22:909–14
   PubMed Web of Science ®Google Scholar
• Haneberg B, Dalseg R, Wedege E, et al. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun 1998;66:1334–41
   PubMed Web of Science ®Google Scholar
• Tamura S, Asanuma H, Ito Y, et al. Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice. Vaccine 1994;12:310–16
   PubMedGoogle Scholar
• Quan CP, Berneman A, Pires R, et al. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997;65:3997–4004
   PubMed Web of Science ®Google Scholar
• Doel TR, Chong WK. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch Virol 1982;73:185–91
   PubMedGoogle Scholar
• Randrup A. Ultracentrifugation of the virus of foot-and-mouth disease: IV. Splitting of the greater complement-fixing particle. Acta Pathol Microbiol Scand 1954;34:366–74
   PubMedGoogle Scholar
• Burroughs JN, Rowlands DJ, Sangar DV, et al. Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol 1971;13:73–84
   PubMedGoogle Scholar
• Saiz JC, Gonzalez MJ, Morgan DO, et al. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res 1989;13:45–60
   PubMedGoogle Scholar